CYP 2.50% 19.5¢ cynata therapeutics limited

Ann: Cynata Strengthens Board & Executive Management Team, page-23

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    If you're long, GvHD is nothing, but agree, it was proof of concept and validation.
    Maybe Fuji think they paid too much for a small indication with much competition.

    Their own presentations and comments/ media don't read like that, but hey, I thought we were gone by end 2018.

    and here we are, still waiting for a simple licence agreement.
    Last edited by Sector: 20/05/19
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.